HLA-A 抗体 (PerCP)
Quick Overview for HLA-A 抗体 (PerCP) (ABIN7807406)
抗原
See all HLA-A 抗体适用
宿主
克隆类型
标记
应用范围
克隆位点
-
-
原理
- Anti-Human HLA-A,B,C Antibody (W6/32), PerCP
-
产品特性
- IgG2a, kappa
-
亚型
- IgG2a, kappa
-
-
anti-Major Histocompatibility Complex, Class I, A (HLA-A) antibody
HLA-A 适用: 人, 小鼠, 大鼠 WB, IF, IHC 宿主: 兔 Polyclonal unconjugated
anti-Major Histocompatibility Complex, Class I, A (HLA-A) (AA 1-365) antibodyHLA-A 适用: 人 WB, IF, IP 宿主: 兔 Polyclonal unconjugated
anti-Major Histocompatibility Complex, Class I, A (HLA-A) (AA 1-365) antibodyHLA-A 适用: 人 FACS, WB 宿主: 小鼠 Polyclonal unconjugated
anti-Major Histocompatibility Complex, Class I, A (HLA-A) (AA 24-365) antibodyHLA-A 适用: 人 WB, ELISA 宿主: 小鼠 Monoclonal 2D6 unconjugated
anti-Major Histocompatibility Complex, Class I, A (HLA-A) antibodyHLA-A 适用: 人 WB, IHC, IP 宿主: 兔 Monoclonal unconjugated
anti-Major Histocompatibility Complex, Class I, A (HLA-A) antibodyHLA-A 适用: 人, 小鼠, 大鼠 WB, IHC, ELISA 宿主: 兔 Polyclonal unconjugated
anti-Major Histocompatibility Complex, Class I, A (HLA-A) (AA 70-99) antibodyHLA-A 适用: 人, 小鼠 WB, IHC, IHC (p) 宿主: 小鼠 Monoclonal unconjugated
anti-Major Histocompatibility Complex, Class I, A (HLA-A) antibodyHLA-A 适用: 人 FACS, IF 宿主: 小鼠 Monoclonal 108-2C5 unconjugated
anti-Major Histocompatibility Complex, Class I, A (HLA-A) (AA 82-106), (N-Term) antibodyHLA-A 适用: 人 WB, IF, IHC, ICC 宿主: 兔 Polyclonal unconjugated
anti-Major Histocompatibility Complex, Class I, A (HLA-A) antibodyHLA-A 适用: 人, 小鼠, 大鼠 WB, IF, IHC, IC 宿主: 兔 Polyclonal unconjugated
-
-
限制
- 仅限研究用
-
-
-
状态
- Liquid
-
缓冲液
- 0.01M PBS, pH 7.4, 0.2 % BSA, 0.05 % Proclin 300.
-
储存液
- ProClin
-
注意事项
- This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
注意事项
- Avoid repeated freeze-thaw cycles
-
储存条件
- 4 °C,-20 °C,-80 °C
-
储存方法
- 4°C for short term (1 week), store at -20°C to -80°C for long term(1 year), Avoid repeated freeze-thaw cycles
-
有效期
- 12 months
-
-
- HLA-A (Major Histocompatibility Complex, Class I, A (HLA-A))
-
别名
- HLA-A
-
背景
- Anti-HLA-A,B,C Monomorphic
-
途径
- TCR Signaling, Regulation of Leukocyte Mediated Immunity, Positive Regulation of Immune Effector Process, Cancer Immune Checkpoints, Human Leukocyte Antigen (HLA) in Adaptive Immune Response
抗原
-
